Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    Granules India gets USFDA approval for Butalbital, Acetaminophen, Caffeine CapsulesGranules India gets USFDA approval for Butalbital, Acetaminophen, Caffeine Capsules
    Cipla gets USFDA final approval for generic version of Proventil HFA Inhalation AerosolCipla gets USFDA final approval for generic version of Proventil HFA Inhalation Aerosol
    No need to panic over availability of PPE: Health ministryNo need to panic over availability of PPE: Health ministry
    US pharmacies authorized to test for COVID-19US pharmacies authorized to test for COVID-19
    Aurobindo Pharma faces CA Suit in US for concealing factsAurobindo Pharma faces CA Suit in US for concealing facts
    Zydus gets USFDA final approval for Imatinib Mesylate TabletsZydus gets USFDA final approval for Imatinib Mesylate Tablets
    With DCGI Nod in hand, Roche launches Breast Cancer Drug Atezolizumab in IndiaWith DCGI Nod in hand, Roche launches Breast Cancer Drug Atezolizumab in India
    Trump has small financial interest in French pharma giant that makes hydroxychloroquine: NYTTrump has small financial interest in French pharma giant that makes hydroxychloroquine: NYT
    Swasth Ke Sipahi delivering essential services and medicines at doorstep of patients and elderly under PMBJPSwasth Ke Sipahi delivering essential services and medicines at doorstep of patients and elderly...
    Merck KEYTRUDA gets USFDA priority review for its Second ApplicationMerck KEYTRUDA gets USFDA priority review for its Second Application
    Jubilant Life Sciences Karnataka plant shut on coronavirus scareJubilant Life Sciences Karnataka plant shut on coronavirus scare
    Zydus gets USFDA final approval for Perphenazine Tablets USPZydus gets USFDA final approval for Perphenazine Tablets USP
    PrevNext

    Popular Stories

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral treatment

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral...

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    Coronavirus Impact: Indian Pharma Exports to miss 22 Billion target, says Pharmexcil

    Coronavirus Impact: Indian Pharma Exports to miss 22 Billion target, says Pharmexcil

    Lasa Supergenerics gets FDA nod for Progesterone

    Lasa Supergenerics gets FDA nod for Progesterone

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok